Expression of CXCR7 in Gastric Cancer Cells and Its Effect on the Migration and Invasion of SGC-7901 Cells

SHI Hai-tao, SHI A-meng, WANG Yan. et al

Abstract

To determine the expression of chemokine (C-X-C motif) receptor 7 (CXCR7) in five gastric cancer cell lines with various degrees of differentiation, and the effect of silencing CXCR7 on the migration and invasion of SGC-7901 cells. Methods The expression of CXCR7 in gastric cell lines (HGC-27, MGC-803, SGC-7901, BGC-823 and MKN-28) was detected by Western bolt and RT-PCR. The SGC-7901 cells were transfected with liposome of CXCR7 siRNA to silence CXCR7 gene, and then treated with stromal-derived factor-1 (SDF-1)——the ligand of CXCR7. Transwell assay was used for determining the migratory and invasive ability of SGC-7901 cells in the four groups: NC siRNA, NC siRNA+SDF-1, CXCR7 siRNA and CXCR7 siRNA+SDF-1. Results CXCR7 was expressed in the five gastric cancer cell lines, with the highest intensity in SGC-7901. The migrated and invasive cells increased in the NC siRNA＋SDF-1 group and reduced in the CXCR7-siRNA group compared with the NC siRNA group (P CXCR7-siRNA＋SDF-1 group had less migrated and invasive cells than the NC siRNA＋SDF-1 group (P CXCR7 siRNA .

 

Keywords: Gastric cancer, CXCR7, Migration Invasion 

 

Full Text:

PDF


References


ORDITURA M. GAIJZIA G, SFORZA V. et al. Treatment of gastric cancer. World J Gastroenterol.2014.20 (7): 1635-1649.

BALKWILL FR. The chemokine system and cancer. J PathoL2012,226(2): 148-157.

SUN X, CHENG G, НAО M. et al. CXCL12/CXCR4/ CXCR7 chemokine axis and cancer progression. Cancer Metast Rev. 2010,9(4) s 709-722.

LEE HJ, JO DY. The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer. Histol Histopathol. 2012,27(9): 1155-1161.

GUILLEMOT К. К A RIМD, К К- SO ILIН1 В. PRADELI К. et al. CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver. Иг J Cancer.2012.107 (12):944-949.

XUETC. CHEN RX. HAN D. et al. Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential. Exp Ther Med,2012,3( 1): 117-123.

YATES TJ. KNAPP J, GOSALBEZ M, et al. C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer. Cancer.2013,119(1):61-71.

НЛО M, ZHENG J. HOU K, et al. Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol,2012.84(2): 204-214.

MELO RC. LONGHINI AL, BIGARELLA CL, et al. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLoS One, 2014, 9 (1): e85926 [2015-09-09]. http://www. ncbi. nlm. nih. gov/pmc/articles/PMC3908922/pdf/pone. 0085926. pdf.

XU H, WU Q. DANG S, et at. Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma. PLoS One, 2011, 6 ( 12): e27399 [2015-09-09]. http:// www. ncbi. nlm. nih. gov/pmc/articles/PMC3236747/pdf/ pone. 0027399. pdf. doi: 10. 1371/journal, pone. 0027399. ZHENG K. LI HY. SU XL, et at. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res.2010,29( 1):31.

MA M. YK JY. DENG R. et al. Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling. Cancer Lett,2011.312 (1 >: 1- 10.

LIU С» PHAM K. LUD D, et al. Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells. PI-oS One.2013.8 (3):e59750 2015-09-09 .. http;//www. ncbi. nlm. nih. gov, pmc/articles/PMC3605406/pdf/pone. 0059750. pdf. doi: 10. 1371/journal, pone. 0059750.

ZHAO BC. WANG ZJ. MAO WZ, et al. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol.2011,17( 19) :2389-2396. LEE HJ, KIM SW. KIM HY, et al. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol.2009.34(2) :473-480.

HU A KF, гнои JC, КА SM, et al. Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-lbeta production.J Cell Physiol.2015,230(4):863-874.

CORSINI K. GALB1ATI V, NIKITOVIC D, et al. Role of oxidative stress in chemical allergens induced skin cells activation. Food Chem Toxicol. 2013 ( 61 ): 74-81 [2015-07- 25]. http://www. sciencedirect. com/science/article/pii/ s0278691513001476. doi:10. 1016/j. fct. 2013.02.038.

A BA IS JM. ZHANG С, X1A M. et al. NADPH oxidase- mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhoniocysteinemia. Antioxid Redox Signal,2013 • 18(13): 1537-1548.

MADALA SK. SCHMIDT S. DAVIDSON C, et al. MKK- KRK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol.2012,46(3) =380-388.

TURNER D, CHAUDHRY A, NKDJAI B. Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Bioscience,2011,32(2): 105-112.

LIAO P. CHAO LK. CHOU JC. et al. Lipopolysaccharide/ adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1- mediated interleukin-1 b secretion. Inflamm Res,2013.62 ( 1): 89-96.

CHENG CY. HO TY. LEE EJ. et al. Ferulic acid reduces cerebral infarct through its antioxidative and anti¬inflammatory effects following transient focal cerebral ischemia in rats. Am J Chin Med.2008.36(6); 1105-1119. XU T. PAN Z. DONG M. et al. Ferulic acid suppresses activation of hepatic stellate cells through ERK1/2 and Smad signaling pathways in vitro. Biochem Pharmacol.2015.93(1): 49-58.

WEI MG. SUN W, HE WM. Et al. Ferulic acid attenuates TGF-pl-induced renal cellular fibrosis in NRK-52E cells by inhibiting Smad/ILK/Snail pathway. Evid Based Complement Alternat Med. 2015 ( 2015): 619720 [2015-08-10]. http,// www. ncbi. nlm. nih. gov,/pmc/articles/PMC4408646/. doi. 10. 1155/2015/619720.


Refbacks

  • There are currently no refbacks.